Literature DB >> 18700620

Role of PGL-I of M. leprae in TNF-alpha production by in vitro whole blood assay.

S Dhungel1, C Ranjit, B R Sapkota, M Macdonald.   

Abstract

Phenolic glycolipid-I (PGL-I) is known to be a major antigen of Mycobacterium leprae. We have studied the influence of PGL-I on the production of Tumour Necrosis Factor alpha (TNF-alpha) using the in vitro whole blood assay. Armadillo-derived M. leprae (ADML) are thought to be depleted of PGL-I during the purification process. M. leprae obtained from mouse foot pad material (MFPML) has been subjected to a less rigorous purification process; their PGL-I coating is therefore believed to be more intact than that of ADML. PGL-I or ADML alone induced the secretion of minimal levels of TNF-alpha in whole blood assay; when added in combination, higher levels of this cytokine were observed. The highest TNF-alpha response was seen following stimulation with MFPML. MFP material not infected with ML did not elicit any response. The difference in TNF-alpha response shown by ADML and MFPML was postulated to be largely due to the presence of higher levels of PGL-I in MFPML. This increase in TNF-alpha production suggests that PGL-I may play a significant role in the induction of TNF-alpha during natural infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18700620

Source DB:  PubMed          Journal:  Nepal Med Coll J


  4 in total

1.  The mycobacterial acyltransferase PapA5 is required for biosynthesis of cell wall-associated phenolic glycolipids.

Authors:  Sivagami Sundaram Chavadi; Kenolisa C Onwueme; Uthamaphani R Edupuganti; Jeff Jerome; Delphi Chatterjee; Clifford E Soll; Luis E N Quadri
Journal:  Microbiology (Reading)       Date:  2012-02-23       Impact factor: 2.777

2.  Modulation of the cytokine response in human monocytes by mycobacterium leprae phenolic glycolipid-1.

Authors:  Claudia Manca; Blas Peixoto; Wladimir Malaga; Christophe Guilhot; Gilla Kaplan
Journal:  J Interferon Cytokine Res       Date:  2011-10-07       Impact factor: 2.607

3.  Inactivation of tesA reduces cell wall lipid production and increases drug susceptibility in mycobacteria.

Authors:  Sivagami Sundaram Chavadi; Uthamaphani R Edupuganti; Olivia Vergnolle; Itrat Fatima; Shaneen M Singh; Clifford E Soll; Luis E N Quadri
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

4.  Mycobacterium leprae alters classical activation of human monocytes in vitro.

Authors:  Dorothy Fallows; Blas Peixoto; Gilla Kaplan; Claudia Manca
Journal:  J Inflamm (Lond)       Date:  2016-03-11       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.